Pharmacyclics (PCYC) News Today → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free pcyc Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlinePCYC Historical Datainvesting.com - September 23 at 9:57 AMPharmacyclics (PCYC) Stock Spikes Today Following $21 Billion AbbVie Merger Dealthestreet.com - March 24 at 8:33 AMPharmacyclics Reaches New 52-Week High (PCYC)thestreet.com - February 24 at 12:11 AMPharmacyclics' Imbruvica Extends Survival in Elderly Leukemia Patientsthestreet.com - January 29 at 8:52 AMASCO '12 Abstract Dump: Cancer Stocks in Focus (Update)thestreet.com - January 13 at 3:41 PMStocks in Motion: Pharmacyclicsthestreet.com - January 2 at 11:33 PMPulnovo Medical Announces Dr. Krishna Sudhir Joins Scientific Advisory Board - StreetInsider.comstreetinsider.com - June 16 at 5:05 AMPulnovo Medical Announces Dr. Krishna Sudhir Joins Scientific Advisory Board - PR Newswireprnewswire.com - June 15 at 2:04 PMNew IMBRUVICA® (ibrutinib) Data in Fixed-Duration Combination Regimen Presented at EHA 2022 Shows Deep, Durable Response at Three Years in Untreated Chronic Lymphocytic Leukemia - StreetInsider.comstreetinsider.com - June 12 at 7:14 PMCritical Limb Ischemia Market to Progress at a CAGR of 10.6% by 2030 | DelveInsight - PR Newswireprnewswire.com - June 7 at 12:34 PMArtiva Biotherapeutics Appoints Dr. Thorsten Graef as Chief Medical Officer - Business Wirebusinesswire.com - June 6 at 4:17 PMGlobal Graft Versus Host Disease (GvHD) Treatment Market Report 2022: Corticosteroids Accounted for More - Benzingabenzinga.com - June 6 at 10:56 AMCelularity Appoints Industry Leader Diane Parks to its Board of Directors - StreetInsider.comstreetinsider.com - June 3 at 1:58 PMRising Star: Covington & Burling's Brianne Bharkhda - Law360law360.com - June 1 at 4:16 PMReal Story: Cancer Drug Maniathestreet.com - April 8 at 10:39 PM Get Pharmacyclics News Delivered to You Automatically Sign up to receive the latest news and ratings for PCYC and its competitors with MarketBeat's FREE daily newsletter. Email Address Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow. Click here for your free guide PCYC Media Mentions By Week PCYC Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PCYC News Sentiment▼0.000.41▲Average News Sentiment PCYC News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PCYC Articles This Week▼00▲PCYC Articles Average Week Get Pharmacyclics News Delivered to You Automatically Sign up to receive the latest news and ratings for PCYC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PCYC) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldAI finds its first serious applicationWall Street StarHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupTrump is sounding the alarmPreserve GoldHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharmacyclics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
